| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10013058 | HBV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS10013059 | HBV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS30000173 | HIV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS30010245 | HIV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS30006101 | HIV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS30006102 | HIV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS30032309 | HIV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS30032310 | HIV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS30032311 | HIV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
| TVIS20067511 | HPV | ENSG00000060982.15 | protein_coding | BCAT1 | No | No | 586 | P54687 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | BCAT1 |
|---|---|
| DrugBank ID | DB00114 |
| Drug Name | Pyridoxal phosphate |
| Target ID | BE0000517 |
| UniProt ID | P54687 |
| Regulation Type | cofactor |
| PubMed IDs | 12269802 |
| Citations | Yennawar NH, Conway ME, Yennawar HP, Farber GK, Hutson SM: Crystal structures of human mitochondrial branched chain aminotransferase reaction intermediates: ketimine and pyridoxamine phosphate forms. Biochemistry. 2002 Oct 1;41(39):11592-601. |
| Groups | Approved; Investigational; Nutraceutical |
| Direct Classification | Pyridoxals and derivatives |
| SMILES | CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O |
| Pathways | Histidinemia; 3-Methylglutaconic Aciduria Type I; Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); beta-Ketothiolase Deficiency; Tyrosine Metabolism; Disulfiram Action Pathway; Hyperprolinemia Type II; Glutamate Metabolism; Argininosuccinic Aciduria; Tyrosinemia Type I; Hyperinsulinism-Hyperammonemia Syndrome; Porphyrin Metabolism; 2-Methyl-3-hydroxybutryl-CoA Dehydrogenase Deficiency; Glutaric Aciduria Type I; Propanoate Metabolism; Taurine and Hypotaurine Metabolism; Catecholamine Biosynthesis; Glycine and Serine Metabolism; Carnitine Synthesis; Tyrosinemia Type 3 (TYRO3); Selenoamino Acid Metabolism; Carbamoyl Phosphate Synthetase Deficiency; Hyperprolinemia Type I; Saccharopinuria/Hyperlysinemia II; Histidine Metabolism; Cystathionine beta-Synthase Deficiency; Arginine and Proline Metabolism; Starch and Sucrose Metabolism; Globoid Cell Leukodystrophy; Ammonia Recycling |
| PharmGKB | PA164749650 |
| ChEMBL | CHEMBL82202 |
